Aachen, Germany

Erol Meyda

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Boehringer Ingelheim Vetmedica Gmbh. Active years: 2021.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Erol Meyda: Innovator in Biological Sample Testing

Introduction

Erol Meyda is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of biological sample testing through his innovative methods and systems. His work is particularly relevant in the context of improving the accuracy and efficiency of testing biological samples.

Latest Patents

Erol Meyda holds a patent for a "Method and analysis system for testing a sample." This analysis system and method are designed for testing biological samples, where the sample and/or analytes are temperature-controlled in advance or denatured immediately before the test. The system also involves heating, with heat being transferred through a chip of a sensor apparatus. This innovative approach enhances the reliability of test results.

Career Highlights

Erol Meyda is currently employed at Boehringer Ingelheim Vetmedica GmbH, a leading company in the veterinary pharmaceutical industry. His role at the company allows him to apply his expertise in developing advanced testing methods that benefit both the scientific community and the veterinary field.

Collaborations

Erol has collaborated with notable colleagues such as Axel Niemeyer and Harald Pauls. Their combined efforts contribute to the advancement of technologies in biological testing.

Conclusion

Erol Meyda's contributions to the field of biological sample testing through his innovative patent and work at Boehringer Ingelheim Vetmedica GmbH highlight his importance as an inventor. His dedication to improving testing methods continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…